SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-19-030477
Filing Date
2019-06-10
Accepted
2019-06-10 17:15:45
Documents
2
Period of Report
2019-06-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv523288_8k.htm 8-K 19666
2 EXHIBIT 10.1 tv523288_ex10-1.htm EX-10.1 10646
  Complete submission text file 0001144204-19-030477.txt   31503
Mailing Address 7 CLARKE DRIVE CRANBURY NJ 08512
Business Address 7 CLARKE DRIVE CRANBURY NJ 08512 6096193990
Outlook Therapeutics, Inc. (Filer) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-37759 | Film No.: 19889247
SIC: 2836 Biological Products, (No Diagnostic Substances)